EVOK - Evoke Pharma Inc. (EVOK) CEO David Gonyer on Q1 2021 Results - Earnings Call Transcript

Evoke Pharma, Inc. (EVOK) Q1 2021 Earnings Conference Call May 12, 2021, 16:30 ET Company Participants Christine Petraglia - The Ruth Group David Gonyer - Co-Founder, CEO, President & Director Christopher Quesenberry - Chief Commercial Officer, Gimoti Matthew D'Onofrio - Co-Founder, Chief Business Officer, Executive VP, Treasurer & Secretary Conference Call Participants Yale Jen - Laidlaw & Company Presentation Operator Good afternoon, and thank you for joining Evoke Pharma's First Quarter 2021 Earnings Conference Call. I would now like to introduce Christine Petraglia for opening remarks. Christine Petraglia Good afternoon, and welcome to Evoke Pharma's First Quarter 2021 Earnings Conference Call and Audio Webcast. With me today are Dave Gonyer, Evoke's Chief Executive Officer; and Matt D'Onofrio, Chief Business Officer; as well as Chris Quesenberry from EVERSANA as GIMOTI's Chief Commercial Officer. Earlier today, Evoke issued a press release announcing financial results for the first quarter ended March 31, 2021.

For further details see:

Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q1 2021 Results - Earnings Call Transcript